The biological action of hyaluronan on human osteoartritic articular chondrocytes: The importance of molecular weight

Clinical and Experimental Rheumatology

Volumn 22, Issue 3, 2004, Pages 307-312

  Maneiro, Emilia ^a   de Andres, María C ^a   Fernández Sueiro, José L ^a   Galdo, Fausto ^a,b   Blanco, Francisco J ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

Apoptosis; Chondrocytes; Hyaluronan; Molecular weight; Nitric oxide; Osteoarthritis

Indexed keywords

HYALURONIC ACID; INTERLEUKIN 1; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PROSTAGLANDIN E2;

ADULT; AGED; APOPTOSIS; ARTICLE; CARTILAGE; CARTILAGE CELL; CELL CULTURE; CELL ISOLATION; CELL STIMULATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG FORMULATION; DRUG MECHANISM; ELECTROIMMUNOASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; JOINT PROSTHESIS; MEASUREMENT; MOLECULAR WEIGHT; OSTEOARTHRITIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; QUANTITATIVE ANALYSIS; REACTION ANALYSIS; SUPERNATANT; VISCOELASTICITY;

ADJUVANTS, IMMUNOLOGIC; APOPTOSIS; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ANTAGONISM; HYALURONIC ACID; INTERLEUKIN-1; MOLECULAR WEIGHT; NITRIC OXIDE; OSTEOARTHRITIS;

EID: 2342510328     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. JACKSON RL, BUSCH SJ, CARDIN AD: Glycosaminoglycans: molecular properties, protein interactions and role in physiological processes. Physiol Rev 1991; 71: 481-538.
2. SMITH MM, GOSH P: The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment. Rheumatol Int 1987; 7: 113-22.
3. BRANDT KD, SMITH GN Jr, SIMON LS: Intrarticular injection of hyaluronan as treatment for knee osteoarthritis; what is the evidence ? Arthritis Rheum 2000; 43: 1192-1203.
4. ENTWISTLE J, HALL CHL, TURLEY EA: HA receptors: regulators of signaling to the cytoskeleton. J Cell Bioch 1996; 61: 569-77.
5. MCKEE CM, PENNO MB, COWMAN M et al.: Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest 1996; 98: 2403-13.
6. POHL M, SAKURAI H, STUART RO, NIGAM SK: Role of hyaluronan and CD44 in in vitro branching morphogenesis of ureteric bud cells. Dev Biol 2000; 224: 312-25.
7. BOURGUIGNON LYW, LOKESHWAR VB, CHEN X, KERRICK WGL: Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction. J Immunology 1993; 151: 6634-44.
8. BALAZS EA, WATSON D, DUFF IF, ROSEMAN S: Hyaluronic acid in synovial fluid. Molecular parameters of hyaluronic acid in normal and arthritis human fluids. Arthritis Rheum 1967; 10: 357-76.
9. DAHL LB, DAHL IMS, ENGSTROM-LAURENT A, GRANATH K: Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 1985; 44: 817-22.
10. ALTMAN RD, MOSKOWITZ R, and the HYALGAN STUDY GROUP: Intra-articular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. J Rheumatol 1998; 25: 2203-12.
11. GOTOH S, ONAYA JI, ABE M et al.: Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. Ann Rheum Dis 1993; 52: 817-22.
12. GHOSH P: The role of hyaluronic acid in health and disease: interactions with cells, cartilage and components of the synovial fluid. Clin Exp Rheumatol 1994; 12: 75-82.
13. YASUI T, ADATSUKA M, TOBETTO K, HAYAISHI M, ANTO T: The effect of hyaluronan on IL-1 induce PGE2 production in human OA synovial cells. Agents Actions 1992; 37: 155-6.
14. TOBETTO K, UASUI T, ANDO T: Inhibitory effects of hyaluronan on (14C) arachidonic acid release from labeled human synovial fibroblasts. Jpn J Pharmacol 1992; 60: 79-84.
15. LISIGNOLI G, GRASSI F, ZINI N et al.: Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan. Arthritis Rheum 2001; 44: 1800-7.
16. TAKAHASHI K, HASHIMOTO S, KUBO T, HIRASAWA Y, LOTZ M, AMIEL D: Effect of hyaluronan on chondrocyte apoptosis and nitric oxide production in experimentally induced osteoarthritis. J Rheumatol 2000; 27: 1713-20.
17. McKEE CM, LOWESTEIN CJ, HORTON MR et al.: Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor KB-dependent mechanism. J Biol Chem 1997;272:8013-18.
18. PRESTI D, SCOTT JE: Hyaluronan mediated protective effect against cell damage caused by enzymatically generated hydroxyl radicals is dependent on hyaluronan molecular mass. Cell Biochem Funct 1994; 12: 281-8.
19. MANEIRO E, MARTÍN MA, DE ANDRÉS MC et al.: Mitochondrial respiratory activity is altered in OA human articular chondrocytes. Arthritis Rheum 2003; 48: 700-8.
20. BLANCO FJ, LOTZ MK: IL-1 induced nitric oxide inhibits chondrocyte proliferation via PGE2. Exp Cell Res 1995; 218: 319-25.
21. BLANCO FJ, GUITIAN R, de TORO FJ, GALDO F: NSAIDs effect in COX-1 and COX-2 activity on human articular chondrocytes. J Rheumatol 1999; 26: 1366-73.
22. BLANCO FJ, GUITIAN R, VÁZQUEZ-MARTUL E, de TORO FJ, GALDO F: Osteoarthritis chondrocytes die by apoptosis. Arthritis Rheum 1998; 41: 284-9.
23. BLANCO FJ, OCHS RL, SCHWARZ H, LOTZ M: Chondrocytes apoptosis induced by nitric oxide. Am J Pathol 1995; 146: 75-85.
24. GHOSH P, GUIDOLIN D: Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: Are the effects molecular weight dependent ? Semin Arthritis Rheum 2002; 32: 10-37.
25. NEUSTADT DH: Long-term efficacy and safety of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Clin Exp Rheumatol 2003, 21: 307-11.
26. LO GH, LaVALLEY M, McALINDON T, FELSON DT: Intraarticular hyaluronic acid in treatment of knee OA: a metaanalysis. JAMA 2003. 290: 3115-21.
27. POZO MA, BALAZAS EA, BELMONTE C: Reduction of sensory responses to passive movements of inflamed knee joints by hylan, a hyaluronan derivative. Exp Brain Res 1997; 116: 3-9.